CT-based 3D dose-volume parameter of the rectum and late rectal complication in patients with cervical cancer treated with high-dose-rate intracavitary brachytherapy

Journal of Radiation Research

Volumn 51, Issue 2, 2010, Pages 215-221

  Kato, Shingo ^a   Tran, Dang Ngoc Linh ^b   Ohno, Tatsuya ^c   Nakano, Takashi ^d   Kiyohara, Hiroki ^a   Ohkubo, Yu ^a   Kamada, Tadashi ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b Ho Chi Minh City Oncology Hospital   (Viet Nam)

^c GUNMA UNIVERSITY HEAVY ION MEDICAL CENTER   (Japan)

^d GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

3D image based brachytherapy; Cervical cancer; Dose volume histogram; High dose rate intracavitary brachytherapy; Late rectal complication

Indexed keywords

COMPUTERIZED TOMOGRAPHY; DISEASES; DOSIMETRY; GRAPHIC METHODS; ONCOLOGY; PATIENT MONITORING;

3-D IMAGE; 3D IMAGE-BASED BRACHYTHERAPY; 3D-IMAGES; BRACHYTHERAPY; CERVICAL CANCERS; DOSE-VOLUME HISTOGRAMS; HIGH DOSE RATE; HIGH-DOSE-RATE INTRACAVITARY BRACHYTHERAPY; IMAGE-BASED; LATE RECTAL COMPLICATION;

RADIOTHERAPY;

EID: 77049088123     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1269/jrr.09118     Document Type: Article

References (30)

1. Eifel PJ, et al (1995) Time course and incidence of late complications in patients treated with radiotherapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 32: 1289-1300.
2. Nakano T, et al (2005) Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix. Cancer 103: 92-101.
3. International Commission on Radiation Units and Measurements (1985) ICRU report 38: Dose and volume specification for reporting intracavitary therapy in gynecology. Bethesda, MD: International Commission on Radiation Units and Measurements.
4. Perez CA, et al (1984) Radiation therapy alone in treatment of carcinoma of the uterine cervix: II. Analysis of complications. Cancer 54: 235-246.
5. Pourquier H, Dubois JB and Deland R (1982) Cancer of the uterine cervix: dosimetric guidelines for prevention of late rectal and rectosigmoid complications as a result of radiotherapeutic treatment. Int J Radiat Oncol Biol Phys 8: 1887-1895.
6. Clark BG, et al (1997) The prediction of late rectal complications in patients treated with high dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 38: 989-993.
7. Kim TH, et al (2005) Dosimetric parameters that predict late rectal complications after curative radiotherapy in patients with uterine cervical carcinoma. Cancer 104: 1304-1311.
8. Ferrigno R, et al (2001) High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications. Int J Radiat Oncol Biol Phys 50: 1123-1135.
9. Kapp KS, et al (1997) Carcinoma of the cervix: analysis of complications after primary external beam radiation and Ir- 192 HDR brachytherapy. Radiother Oncol 42: 143-153.
10. Katz A and Eifel PJ (2000) Quantification of intracavitary brachytherapy parameters and correlation with outcome in patients with carcinoma of the cervix. Int J Radiat Oncol Biol Phys 48: 1417-1425.
11. Van den Berg F, et al (1998) The use of transverse CT image for the estimation of the dose given to the rectum in intracavitary brachytherapy for carcinoma of the cervix. Radiother Oncol 47: 85-90.
12. Wachter-Gerstner N, et al (2003) Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: Comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point. Radiother Oncol 68: 269-276.
13. Haie-Meder C, et al (2005) Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 74: 235-245.
14. Pötter R, et al (2006) Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy - 3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 78: 67-77.
15. Kirisits C, et al (2005) Dose and volume parameters for MRI- based treatment planning in intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys 62: 901-911.
16. Lang S, et al (2006) Intercomparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GEC-ESTRO recommendations. Radiother Oncol 78: 185-193.
17. Dimopoulos J, et al (2009) Dose-volume histogram parameters and local tumor control in magnetic resonance imageguided cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys 75: 56-63.
18. Georg P, et al (2009) Correlation of dose-volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI- based brachytherapy. Radiother Oncol 91: 173-180.
19. Koom WS, et al (2007) Computed tomography-based high- dose-rate intracavitary brachytherapy for uterine cervical cancer: Preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy. Int J Radiat Oncol Biol Phys 68: 1446-1454.
20. Pötter R, et al (2006) 3D conformal HDR-brachy- and external beam therapy plus simultaneous Cisplatin for high-risk cervical cancer: Clinical experience with 3 year follow-up. Radiother Oncol 79: 80-86.
21. Noda S, et al (2007) Late rectal complications evaluated by computed tomography-based dose calculations in patients with cervical carcinoma undergoing high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 69: 118-124.
22. Japan Society of Obstetrics and Gynecology, The Japanese Pathological Society, and Japan Radiological Society, editors (1987) The general rules for clinical and pathological management of uterine cervical cancer. Kanehara Shuppan, Tokyo.
23. Cox JD, Stetz J and Pajak TF (1995) Toxicity criteria of the Radiotherapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31: 1341-1346.
24. Pelloski CE, et al (2005) Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 62: 131-137.
25. Yaparpalvi R, et al (2008) Point vs. Volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose- rate brachytherapy: Correlation and comparison with published Vienna applicator data. Brachytherapy 7: 336-342.
26. Wang B, et al (2009) Image-guided intracavitary high-dose- rate brachytherapy for cervix cancer: A single institutional experience with three-dimensional CT-based planning. Brachytherapy 8: 240-247.
27. Nag S, et al (2004) Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: Report from image-guided brachytherapy working group. Int J Radiat Oncol Biol Phys 60: 1160-1172.
28. Viswanathan AN, et al (2007) Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: Results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oncol Biol Phys 68: 491-498.
29. Hellebust TP, et al (2001) Inter fraction variations in rectum and bladder volumes and dose distributions during high dose rate brachytherapy treatment of the uterine cervix investigated by repetitive CT-examinations. Radiother Oncol 60: 273-280.
30. Kirisits C, et al (2006) Uncertainties when using only one MRI-based treatment plan for subsequent high-dose-rate tandem and ring applicators in brachytherapy for cervix cancer. Radiother Oncol 81: 269-275.